Triciribine, API-2, NSC 154020, Tricyclic Nucleoside CAS 35943-35-2

With the help of our sophisticated in-house facilities, we offer superior quality Triciribine CAS 35943-35-2 to our customers. We use well-test raw material which is from certified vendors of the markets, and adopt the most advanced technology to make it. Triciribine CAS NO 35943-35-2 is high specification and micronized that appreciated by customers with the molecular formula C13H16N6O4 and formula weight 320.3. Triciribine 35943-35-2 is white powder that is Akt/PKB Signaling Inhibitor-2, and Soluble in 1eq. HCl (100 mM), and DMSO (100 mM).

Thera. Category: Anti-cancer

Cas No.: 35943-35-2

Synonym: API-2;6-AMINO-4-METHYL-8-(BETA-D-RIBOFURANOSYL)-4H,8H-PYRROLO[4,3,2-DE]PYRIMIDO[4,5-C]PYRIDAZINE;AKT/PKB SIGNALING INHIBITOR-2;Akt Inhibitor V;1,5-DIHYDRO-5-METHYL-1-BETA-D-RIBOFURANOSYL-1,4,5,6,8-PENTAAZAACENAPHTHYLEN-3-AMINE;1,4,5,6,8-pentaazaacenaphthylen-3-amine,1,5-dihydro-5-methyl-1-beta-d-ribofura;1,4,5,6,8-pentaazaacenaphthylene,3-amino-1,5-dihydro-5-methyl-1-beta-d-ribof;3-amine

Molecular Formula: C13H16N6O4

Molecular Weight: 320.3

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:

Triciribine 35943-35-2 , also known as API-2, suppresses the phosphorylation level and kinase activity of Akt. Akt kinase inhibition has been shown to induce apoptosis and cell growth in Cancer Cell research. Triciribine can selectively inhibit Akt1, Akt2, and Akt3 without inhibiting known upstream activators,PDK1 and PI 3-Kinase, of Akt. Studies show that Triciribine in duces apoptosis and inhibits cell growth in cells that express atypical Akt1. Additionally, Triciribine has antineoplastic and antiviral activity at low micromolar and submicromolar concentrations, and has been demonstrated to inhibit incorporation of amino acids into proteins and purine nucleotide synthesis.

Product Categories : Inhibitors > AKT Inhibitor